HOME › DRUGS › SUTIMLIMAB
ACTIVE SUBSTANCE / INN

SUTIMLIMAB

Brand name(s): Enjaymo
EMA LISTED
AUTHORISED
Hemolysis;Anemia, Hemolytic, Autoimmune
ACTIVE SUBSTANCE
Sutimlimab
REGULATORS
EMA
SPONSORS / MAH
Recordati Rare Diseases
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EnjaymoRecordati Rare DiseasesAuthorised15/11/2022Hemolysis;Anemia, Hemolytic, Autoimmune

FULL INTELLIGENCE ON SUTIMLIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →